Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Christopher M. Knapp"'
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0133154 (2015)
Short interfering ribonucleic acid (siRNA) therapeutics show promise for the treatment of intestinal diseases by specifically suppressing the expression of disease relevant proteins. Recently, a class of lipid-like materials termed "lipidoids" have b
Externí odkaz:
https://doaj.org/article/ab47de8821314ab6b724adea1260b7f7
Publikováno v:
Experimental Biology and Medicine. 244:865-872
Mantle cell lymphoma is an aggressive subtype of non-Hodgkin’s lymphoma that claims the lives of tens of thousands of people every year. Although combination chemotherapy treatments such as CHOP have yielded promising outcomes in the clinic, the de
Publikováno v:
Bioengineering & Translational Medicine
Mantle cell lymphoma is an aggressive and incurable subtype of non‐Hodgkin B cell lymphoma. Patients typically present with advanced disease, and most patients succumb within a decade of diagnosis. There is a clear and urgent need for novel therape
Publikováno v:
Cellular and Molecular Bioengineering. 9:305-314
RNA interference therapeutics have been limited, in large part, by the lack of efficient, non-toxic, non-immunogenic delivery systems. Among previously established methods, lipidoid nanoparticles (LNPs) show particular promise in delivering siRNA to
Autor:
Arsenovic Nebojsa, Peter M. Mota, Alexander J. Brent, Antonella Berry-Brincat, Christopher M. Knapp
Publikováno v:
Canadian Journal of Ophthalmology. 52:e235-e237
Publikováno v:
BMC Ophthalmology, Vol 19, Iss 1, Pp 1-3 (2019)
BMC Ophthalmology
BMC Ophthalmology
Background It has been previously reported that one copy of the variable number tandem repeat (VNTR) B alleles of the GPIbα gene increases the risk of non-arteritic ischaemic optic neuropathy (NAION) and the second eye involvement. This is the first
Autor:
Sarah B. Deluty, Shridhar Singh, Daria Strelkova, Rebecca L. Ball, Khalid A. Hajj, Kathryn A. Whitehead, Christopher M. Knapp
Publikováno v:
Small (Weinheim an der Bergstrasse, Germany). 15(6)
The potential of mRNA therapeutics will be realized only once safe and effective delivery systems are established. Unfortunately, delivery vehicle development is stymied by an inadequate understanding of how the molecular properties of a vehicle conf
Publikováno v:
Expert Opinion on Drug Delivery. 11:1923-1937
Non-Hodgkin lymphoma (NHL) is diagnosed in 70,000 Americans annually. Chemotherapy was the standard course of treatment until the addition of the monoclonal antibody (mAb) drug, rituximab, to therapy regimens in 1997. Although disease prognosis has i
Publikováno v:
Strabismus. 21:37-49
Optokinetic nystagmus (OKN) is a reflex eye movement induced by motion of the whole or a large proportion of the visual field. It can be horizontal, vertical, and torsional in direction and consists of two basic components, a slow tracking movement a
Publikováno v:
PLoS ONE
PLoS ONE, Vol 10, Iss 7, p e0133154 (2015)
PLoS ONE, Vol 10, Iss 7, p e0133154 (2015)
Short interfering ribonucleic acid (siRNA) therapeutics show promise for the treatment of intestinal diseases by specifically suppressing the expression of disease relevant proteins. Recently, a class of lipid-like materials termed "lipidoids" have b